By Mary Ann Liebert, Inc. | October 18, 2018Novel DNA Vaccine Design Offers Broad Protection Against Influenza-A H3N2
By Mary Ann Liebert, Inc. | January 31, 2018New Study Shows Severe Toxicity with High-Dose AAV9-Based Gene Therapy in Animal Models
